Compare, Analyse PLETHICO PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   ACTAVIS
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ACTAVIS
Dec-18
PLETHICO PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs39513,781-   
Low Rs319,244-   
Sales per share (Unadj.) Rs604.43,380.5-  
Earnings per share (Unadj.) Rs32.5-1,088.9-  
Cash flow per share (Unadj.) Rs51.3356.2-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.613,942.9-  
Shares outstanding (eoy) m34.08332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.43.4 10.4%   
Avg P/E ratio x6.6-10.6 -62.1%  
P/CF ratio (eoy) x4.232.3 12.8%  
Price / Book Value ratio x0.50.8 54.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,2623,829,128 0.2%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1,5960-   
Avg. sales/employee Rs ThNM66,529.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-21,429.2-  
INCOME DATA
Net Sales Rs m20,5981,124,350 1.8%  
Other income Rs m38621,501 1.8%   
Total revenues Rs m20,9841,145,851 1.8%   
Gross profit Rs m2,81829,464 9.6%  
Depreciation Rs m642480,635 0.1%   
Interest Rs m1,59364,881 2.5%   
Profit before tax Rs m969-494,552 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0126,131 0.0%   
Tax Rs m-138-6,267 2.2%   
Profit after tax Rs m1,107-362,154 -0.3%  
Gross profit margin %13.72.6 522.0%  
Effective tax rate %-14.31.3 -1,127.5%   
Net profit margin %5.4-32.2 -16.7%  
BALANCE SHEET DATA
Current assets Rs m18,877461,150 4.1%   
Current liabilities Rs m11,896407,948 2.9%   
Net working cap to sales %33.94.7 716.2%  
Current ratio x1.61.1 140.4%  
Inventory Days Days3620 183.5%  
Debtors Days Days19866 298.3%  
Net fixed assets Rs m9,861127,270 7.7%   
Share capital Rs m3410-   
"Free" reserves Rs m12,3310-   
Net worth Rs m16,1394,637,419 0.3%   
Long term debt Rs m4,7061,633,003 0.3%   
Total assets Rs m33,1467,249,341 0.5%  
Interest coverage x1.6-6.6 -24.3%   
Debt to equity ratio x0.30.4 82.8%  
Sales to assets ratio x0.60.2 400.7%   
Return on assets %8.1-4.1 -198.7%  
Return on equity %6.9-7.8 -87.8%  
Return on capital %12.3-4.8 -253.9%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,437401,688 0.6%  
From Investments Rs m-6,265220,675 -2.8%  
From Financial Activity Rs m2,490-689,417 -0.4%  
Net Cashflow Rs m-1,337-66,719 2.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare PLETHICO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PLETHICO PHARMA With: ABBOTT INDIA  FDC LTD.  CADILA HEALTHCARE  IPCA LABS  PANACEA BIOTECH  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS